Influx Healthtech (NSE:INFLUX) Total Assets: ₹1,237 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INFLUX Influx Healthtech Ltd NSE:INFLUX
21 GF Score
Price ₹285.00
! 4 Warning Signs
View Full Analysis

What is Influx Healthtech Total Assets?

Influx Healthtech NSE:INFLUX -1.77% 21 Total Assets is ₹1,237 Mil as of Mar. 2026. GuruFocus rates NSE:INFLUX with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Influx Healthtech's Total Assets for the quarter that ended in Mar. 2026 was ₹1,237 Mil.

During the past 12 months, Influx Healthtech's average Total Assets Growth Rate was 40.70% per year. During the past 3 years, the average Total Assets Growth Rate was 57.20% per year.

During the past 5 years, Influx Healthtech's highest 3-Year average Total Assets Growth Rate was 61.90%. The lowest was 57.20%. And the median was 59.55%.

Total Assets is connected with ROA %. Influx Healthtech's annualized ROA % for the quarter that ended in Mar. 2026 was 17.75%. Total Assets is also linked to Revenue through Asset Turnover. Influx Healthtech's Asset Turnover for the quarter that ended in Mar. 2026 was 0.67.


Influx Healthtech  (NSE:INFLUX) Total Assets Explanation

Total Assets is connected with ROA %.

Influx Healthtech's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=210.518/( (1135.402+1237.03)/ 2 )
=210.518/1186.216
=17.75 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Influx Healthtech's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=800.69/( (1135.402+1237.03)/ 2 )
=800.69/1186.216
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Influx Healthtech Total Assets Related Terms


Influx Healthtech Total Assets Historical Data

* Premium members only.

The historical data trend for Influx Healthtech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Influx Healthtech Total Assets Chart

Influx Healthtech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Assets
175.88 283.04 411.03 702.99 1,237.03

Influx Healthtech Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Assets Get a 7-Day Free Trial 411.03 0.00 702.99 1,135.40 1,237.03
NSE:INFLUX
21GF Score
Influx Healthtech Ltd NSE:INFLUX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Influx Healthtech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Influx Healthtech's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=1007.571+229.459
=1,237

Influx Healthtech's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=1007.571+229.459
=1,237

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of ₹1,237 Mil mean?
Influx Healthtech (NSE:INFLUX) has a Total Assets of ₹1,237 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Influx Healthtech and its competitors.
Is Influx Healthtech's Total Assets too high?
Influx Healthtech's current Total Assets is ₹1,237 Mil. Overall, Influx Healthtech has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Influx Healthtech's Total Assets compare to ZTS?
Influx Healthtech's Total Assets of ₹1,237 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Influx Healthtech and its competitors. Influx Healthtech's current Total Assets is ₹1,237 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Influx Healthtech stock overvalued right now?
Influx Healthtech (NSE:INFLUX) has a current Total Assets of ₹1,237 Mil. The current Total Assets is ₹1,237 Mil. Influx Healthtech's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Influx Healthtech (NSE:INFLUX), the current Total Assets is ₹1,237 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Influx Healthtech Business Description

Address Plot No. 856, 109, Ghanshyam Enclave Premises Co-op Society, Behind Laljipada Police Chowky, Kandivali West, Mumbai, MH, IND, 400067
Influx Healthtech Ltd is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates manufacturing facilities located in Thane. Its expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables. The company generates the majority of its revenue from sale of products.
21GF Score

Get the complete analysis for NSE:INFLUX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹285.00
Price